Shockwaves in your heart: new device zaps artery calcium

NCT ID NCT07259239

Recruiting now Disease control Sponsor: National Heart Centre Singapore Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called the SoniCracker IVL, which uses tiny shockwaves to break up hard calcium deposits in heart arteries. The goal is to make it easier to place stents and improve blood flow. About 40 adults with calcified coronary arteries will be enrolled. Researchers will check if the device can be delivered safely and if it leads to successful stent placement without major heart complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: SoniCracker IVL device (a catheter that delivers shockwaves to break up calcium in heart arteries)
What this could lead to: If successful, this device could offer a safer, more effective way to treat heavily calcified heart arteries, potentially reducing the risk of heart attacks and the need for repeat procedures.
What could go wrong: This is a small, early feasibility study with only 40 participants, so results may not apply to everyone. The device may fail to break up calcium or could cause artery damage, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CALCIFIED CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder coronary atherosclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES

Contacts and locations

Locations

National Heart Center Singapore
RECRUITING

Singapore, 169609, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.